Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation

Liver Transplantation

Volumn 14, Issue 3, 2008, Pages 346-357

  Toyokawa, Hideyoshi ^a   Nakao, Atsunori ^a   Bailey, Robert J ^a   Nalesnik, Michael A ^a   Kaizu, Takashi ^a   Lemoine, Jerome L ^a   Ikeda, Atsushi ^a   Tomiyama, Koji ^a   Papworth, Glenn D ^a   Huang, Leaf ^a,b   Demetris, Anthony J ^a   Starzi, Thomas E ^a   Murase, Noriko ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; CD68 ANTIGEN; CLODRONIC ACID; GLYCOPROTEIN P 15095; LIPOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TACROLIMUS;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CARDIAC GRAFT REJECTION; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; DENDRITIC CELL; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MACROPHAGE; MALE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; SURVIVAL RATE; TH1 CELL; TRANSPLANTATION TOLERANCE; UPREGULATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; CLODRONIC ACID; DENDRITIC CELLS; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE TOLERANCE; LEUKOCYTES; LIPOSOMES; LIVER TRANSPLANTATION; MACROPHAGES; MALE; PHAGOCYTOSIS; RATS; RATS, INBRED BN; RATS, INBRED LEW; TRANSPLANTATION TOLERANCE;

EID: 41149155327     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21378     Document Type: Article

References (50)

1. Lechler RI, Batchelor JR. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 1982; 155:31-41.
2. Larsen CP, Morris PJ, Austyn JM. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J Exp Med 1990; 171:307-314.
3. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992;339:1579-1582.
4. Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, Ildstad S, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993;17:1127-1152.
5. Sun J, McCaughan GW, Gallagher ND, Sheil AG, Bishop GA. Deletion of spontaneous rat liver allograft acceptance by donor irradiation. Transplantation 1995;60:233-236.
6. Josien R, Heslan M, Brouard S, Soulillou JP, Cuturi MC. Critical requirement for graft passenger leukocytes in allograft tolerance induced by donor blood transfusion. Blood 1998;92:4539-4544.
7. Ko S, Deiwick A, Jager MD, Dinkel A, Rohde F, Fischer R. et al. The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat. Nat Med 1999;5:1292-1297.
8. Lakkis FG, Arakelov A, Konieczny BT, Inoue Y. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 2000;6: 686-688.
9. Gould DS, Auchincloss H Jr. Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol Today 1999;20:77-82.
10. Heeger PS. T-cell allorecognition and transplant rejection: a summary and update. Am J Transplant 2003;3:525-533.
11. Talmage DW, Dart G, Radovich J, Lafferty KJ. Activation of transplant immunity: effect of donor leukocytes on thyroid allograft rejection. Science 1976:191:385-388.
12. Sims TN, Afrouzian M, Unnson J, Zhu LF, Halloran PF. The role of the class II transactivator (CIITA) in MHC class I and II regulation and graft rejection in kidney. Am J Transplant 2001;1:211-221.
13. Smith CR, Jaramillo A, Liu W, Tu Y, Kaleem Z, Swanson CJ, et al. CD4+ T cell recognition of a single discordant HLA-A2-transgenic molecule through the indirect antigen presentation pathway induces acute rejection of murine cardiac allografts. Transplantation 2001;71:1640-1648.
14. Jurcevic S, Chandler P, Sacks SH, Simpson E, Rapid rejection of HLA-A2 transgenic skin graft due to indirect allorecognition. Transplantation 2001;72:994-997.
15. Van Rooijen N. The liposome-mediated macrophage 'suicide' technique. J Immunol Methods 1989;124:1-6.
16. Van Rooijen N, Kors N, vd Ende M, Dijkstra CD. Depletion and repopulation. of macrophages in spleen and liver of rat after intravenous treatment with liposome-encapsulated dichloromethylene diphosphonate. Cell Tissue Res 1990; 260:215-222.
17. Van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 1994;174: 83-93.
18. Sekine Y, Bowen LK, Heidler KM, Van Rooijen N, Brown JW, Cummings OW, et al. Role of passenger leukocytes in allograft rejection: effect of depletion of donor alveolar macrophages on the local production of TNF-alpha, T helper 1/T helper 2 cytokines, IgG subclasses, and pathology in a rat model of lung transplantation. J Immunol 1997;159:4084-4093.
19. Wu G, Korsgren O, Zhang J, Song Z, van Rooijen N, Tibell A. Pig islet xenograft rejection is markedly delayed in macrophage-depleted mice: a study in streptozotocin diabetic animals. Xenotransplantation 2000;7:214-220.
20. Slegers TP, Broersma L, van Rooijen N, Hooymans JM, van Rij G, van der Gaag R. Macrophages play a role in the early phase of corneal allograft rejection in rats. Transplantation 2004;77:1641-1646.
21. Rabinovich GA, Riera CM, Iribarren P. Granulocyte-macrophage colony-stimulating factor protects dendritic cells from liposome-encapsulated dichloromethylene diphosphonate-induced apoptosis through a Bcl-2-mediated pathway. Eur J Immunol 1999;29:563-570.
22. Zhang Y, Shlomchik WD, Joe G, Louboutin JP, Zhu J, Rivera A, et al. APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease. J Immunol 2002; 169:7111-7118.
23. Nikolic T, Geutskens SB, van Rooijen N, Drexhage HA, Leenen PJ. Dendritic cells and macrophages are essential for the retention of lymphocytes in (peri)-insulitis of the nonobese diabetic mouse: a phagocyte depletion study. Lab Invest 2005:85:487-501.
24. Huitinga I, van Rooijen N, de Groot CJ, Uitdehaag BM, Dijkstra CD. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 1990; 172:1025-1033.
25. Okuda T, Ishikawa T, Azhipa O, Ichikawa N, Demetris AJ, StarzI TE, et al. Early passenger leukocyte migration and acute immune reactions in the rat recipient spleen during liver engraftment: with particular emphasis on donor major histocompatibility complex class II+ cells. Transplantation 2002;74:103-111.
26. Murase N, Starzl TE, Tanabe M, Fujisaki S, Miyazawa H, Ye Q, et al. Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation 1995;60:158-171.
27. Yagihashi A, Takahashi S, Murase N, Starzl TE, Iwaki Y. A monoclonal antibody (L21-6) recognizing an invariant chain expressed on the cell surface in rats with the exception of the BN (RT1n): a study of tissue and strain distributions. Transplant Proc 1995;27:1519-1521.
28. Murase N, Kim DG, Todo, S, Cramer DV, Fung J, Starzl TE. FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats. Transplantation 1990;50:739-744.
29. Buiting AM, Zhou F, Bakker JA, van Rooijen N, Huang L. Biodistribution of clodronate and liposomes used in the liposome mediated macrophage 'suicide' approach. J Immunol Methods 1996; 1927:55-62.
30. Ganta SR, Piesco NP, Long P, Gassner R, Motta LF, Papworth GD, et al. Vascularization and tissue infiltration of a biodegradable polyurethane matrix. J Biomed Mater Res A 2003;64:242-248.
31. Demetris AJ, Murase N, Lee RG, Randhawa P, Zeevi A, Pham S, et al. Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. Ann Transplant 1997;2: 27-44.
32. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997;25:658-663.
33. Nakao A, Kimizuka K, Stolz DB, Neto JS, Kaizu T, Choi AM, et al. Carbon monoxide inhalation protects rat intestinal grafts from ischemia/ reperfusion injury. Am J Pathol 2003; 163:1587-1598.
34. Neto JS, Nakao A, Toyokawa H, Nalesnik MA, Romanosky AJ, Kimizuka K, et al. Low-dose carbon monoxide inhalation prevents development of chronic allograft nephropathy. Am J Physiol Renal Physiol 2006;290:F324-F334.
35. Demetris AJ, Murase N, Fujisaki S, Fung JJ, Rao AS, Starzl TE. Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc 1993;25:3337-3344.
36. Murase N, Demetris AJ, Matsuzaki T, Yagihashi A, Todo S, Fung J, et al. Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery 1991;110:87-98.
37. Yan Y, Shastry S, Richards C, Wang C, Bowen DG, Sharland AF, et al. Posttransplant administration of donor leukocytes induces long-term acceptance of kidney or liver transplants by an activation-associated immune mechanism. J Immunol 2001;166:5258-5264.
38. Benichou G, Valujskikh A, Heeger PS. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J Immunol 1999:162:352-358.
39. Csencsits K, Wood SC, Lu G, Magee JC, Eichwald EJ, Chang CH, et al. Graft rejection mediate by CD4 + T cells via indirect recognition of alloantigen is associated with a dominant Th2 response. Eur J Immunol 2005;35:843-851.
40. Demetris AJ, Murase N, Ye Q, Galvao FH, Richert C, Saad R, et al. Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. Am J Pathol 1997; 150:563-578.
41. Ichikawa N, Demetris AJ, Starzl TE, Ye Q, Okuda T, Chun HJ, et al. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection. Liver Transpl. 2000;6:686-702.
42. Fleisch H. Bisphosphonates: a new class of drugs in diseases of bone and calcium metabolism. Handb Exp Pharmacol 1988;83:441.
43. Cebon J, Davis I, Luft T, Maraskovsky E. Dendritic cells as recipients of cytokine signals. In: Lotze MT, Thomson AW, eds. Dendritic Cells. San Diego, CA: Academic Press; 2001: 187-202.
44. Raisanen-Sokolowski A, Mottram PL, Glysing-Jensen T, Satoskar A, Russell ME. Heart transplants in interferon-gamma, interleukin 4, and interleukin 10 knockout mice. Recipient environment alters graft rejection. J Clin Invest 1997;100:2449-2456.
45. Konieczny BT, Dal Z, Elwood ET, Saleem S, Linsley PS, Baddoura FK, et al. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 1998; 160:2059-2064.
46. Dai Z, Konieczny BT, Baddoura FK, Lakkis FG. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice. J Immunol 1998;161:1659-1663.
47. Sawitzki B, Kingsley CI, Oliveira V, Karim M, Herber M, Wood KJ. IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med 2005;201:1925-1935.
48. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 1999;189:1363-1372.
49. Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 2004;4:762-774.
50. Akdis CA, Blaser K. Mechanisms of interleukin-10-mediated immune suppression. Immunology 2001;103:131-136.